NCT05958199 2025-06-27A Study of NPX267 for Subjects With Solid Tumors Known to Express HHLA2/B7-H7NextPoint Therapeutics, Inc.Phase 1 Suspended131 enrolled
NCT00909558 2010-02-24Safety and Effectiveness Study of Autologous Natural Killer and Natural Killer T Cells on CancerEnvita Medical Center, Inc.Phase 1 Suspended24 enrolled